Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Emergent BioSolutions Looks to the Second Half for Growth

TheMotleyFool

0 0

Emergent BioSolutions Looks to the Second Half for Growth

Emergent BioSolutions (NYSE: EBS) continued its transition in the second quarter with another loss on the earnings line. Fortunately, the bioterrorism expert shouldn't take too long to turn things around, because earnings growth is expected in the second half of this year.

Metric

Q2 2019

Quelle Fool.com

Like: 0

EBS

Share